‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy
Rachel Ham, John Gardner, Adrian Carter, Paul LiknaitzkyAbstract
Objectives
Psychedelic‐assisted therapy (
Design
Longitudinal qualitative analysis of participants sampled from a large randomised, open‐label, phase 2 clinical trial of psilocybin‐assisted therapy for
Methods
Qualitative data were collected from
n
= 18 participants via 29 semi‐structured interviews, conducted before and after dosing sessions. Interviews examined experiences of
Results
Three major themes were developed: (1) dose day cotherapy: safety, trust and the realities of access; (2) cotherapy influences therapeutic processes; and (3) cotherapy shapes the impact and credibility of therapeutic insights.
Conclusions
Cotherapy in